SCHEMBL13262147

SCHEMBL13262147

CC(Oc1ccccc1N)Oc1ccccc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
TSHR P16473 2/20 0.45
TP53 P04637 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
ADRA2B P18089 1/20 0.45
PTGS1 P23219 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALOX15 P16050 2/20 0.45
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 2/20 0.38
JAK2 O60674 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
KDM4E B2RXH2 2/20 0.36
CRHBP P24387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872064 0.88 ALDH1A1 (0.56) ALDH1A1TSHRCA1CA2ADRA2B
SCHEMBL8747528 0.88 CA2 (0.56) ALDH1A1TSHRTP53CA1CA2
Acetic Acid SCHEMBL2127698 0.81 ALDH1A1 (0.45) ALDH1A1TSHRADRA2BPTGS1TDP1
SCHEMBL10878354 0.80 CA2 (0.58) ALDH1A1TSHRTP53CA1CA2
SCHEMBL3426863 0.80 ALDH1A1 (0.58) ALDH1A1TSHRCA1CA2ADRA2B
SCHEMBL11771306 0.80 CA2 (0.52) ALDH1A1TSHRTP53CA1CA2
SCHEMBL21693960 0.80 ALDH1A1 (0.44) ALDH1A1TSHRADRA2BPTGS1TDP1
SCHEMBL19973199 0.76 TSHR (0.52) ALDH1A1TSHRTP53CA1CA2
SCHEMBL1369853 0.76 ALDH1A1 (0.52) ALDH1A1TSHRADRA2BPTGS1TDP1
SCHEMBL104203 0.76 TP53 (0.56) ALDH1A1TSHRTP53CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100167333-A1 Heavy Metal Binding Compounds and Their Method of Use Life Technologies Corporation (US) 2010-07-01 US disclosed
US-7521577-B2 Heavy metal binding compounds and their method of use MOLECULAR PROBES, INC. (US) 2009-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100167333-A1 Heavy Metal Binding Compounds and Their Method of Use SLC30A6, SLC30A5, SLC30A7 ALDH1A1 1070/4885TSHR 629/4885TP53 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.